United States

People: Ligand Pharmaceuticals Inc (LGND.O)

LGND.O on Consolidated Issue listed on NASDAQ Global Market

13 Jan 2017
Change (% chg)

$-0.79 (-0.74%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sabba, Stephen 

Dr. Stephen L. Sabba, M.D., serves as an Independent Director of Ligand Pharmaceuticals Inc., since August 4, 2008. Dr. Sabba has been a leading Bio/Pharma Analyst and Fund Manager for Knott Partners, L.P., an investment fund company, since November 2006. Previously he was a Partner and Director of Research with Kilkenny Capital Management, a Chicago-based biomedical hedge fund. Prior to that, Dr. Sabba was Director of Research at Sturza’s Medical Research, and previously was a gastroenterologist and internist in private practice at Phelps Memorial Hospital in North Tarrytown, New York. He received his medical degree from the New York University School of Medicine, and completed a residency in internal medicine and a fellowship in gastroenterology at the Veterans Administration Medical Center in New York City. He earned a Bachelor of Science degree with honors at Cornell University. Dr. Sabba has served as a member of the board of the directors for QLT, Inc., a leading Canadian biotech company, since June 2012. In selecting Dr. Sabba to serve as a director, the board considered, among other things, his capital markets and accounting expertise gained from his prior experience working in the hedge fund and investment fund industries. Ligand also benefits from his background as a medical doctor and from his understanding of medicine.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 83,019
Long-Term Incentive Plans, USD --
All Other, USD 210,010
Fiscal Year Total, USD 293,029

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kozarich


Matthew Foehr


John Higgins


Matthew Korenberg


Charles Berkman


Jason Aryeh

As Of  30 Dec 2015